Methods of reducing the risk of cardiovascular events in a subject
AssigneeAmarin Pharmaceuticals Ireland Limited
InventorParesh Soni
Life of this patent
Estimating the term…
Abstract
In various embodiments, the present disclosure provides methods reducing the risk of cardiovascular events in a subject on statin therapy by administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
Claims17
A method of reducing an incidence of myocardial infarction in a subject with triglyceride levels of greater than 150 mg/dl, said method comprising administering to said subject 4 g of icosapent ethyl, wherein the subject experiences atrial fibrillation and/or flutter instead of an incidence of myocardial infarction.
Dependencies are inferred from the claim text.